ACTUATE THERAPEUTICS INC (ACTU) Stock Income Statement
NASDAQ:ACTU - Nasdaq - US0050831009 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 23.75M | 25.16M | 24.97M | 20.21M | |||
| Research and Development | 15.04M | 18.68M | 21.71M | 16.39M | |||
| Selling, General, and Administrative Expenses | 8.72M | 6.48M | 3.27M | 3.82M | |||
| Operating Income | -23.75M | -25.16M | -24.97M | -20.21M | |||
| Interest Income/Expense | -1.85M | -2.39M | 309.00K | 10.80K | |||
| Other Income/Expense | -46.40K | -78.90K | -79.80K | 36.60K | |||
| Non Recurring Items | N/A | 343.20K | N/A | N/A | |||
| Income Before Taxes | -25.31M | -27.29M | -24.74M | -20.16M | |||
| Net Income | -25.31M | -27.29M | -24.74M | -20.16M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -1.28 | -1.40 | -1.29 | -1.05 | |||
| Statistics | |||||||
All data in USD